Astaxanthin for type 2 diabetic patientsJuly 16, 2018
Astaxanthin (AST) is a natural compound found in seafoods with antioxidant properties several fold higher than vitamin C. It has already been approved as a dietary supplement and could be a potential treatment for inflammation and oxidative stress in cardiovascular diseases. Due to its positive effects on cholesterol and lipid metabolism, Mashhadi et al. set out to determine whether dietary intake of AST can affect lipid profiles and blood sugar levels in type 2 diabetic mellitus patients. In their 8-week clinical study of 44 type 2 diabetes patients, they observed that 8 mg of AST supplementation resulted in significantly reduced visceral body fat mass, increased serum adiponectin, decreased serum triglycerides, decreased systolic blood pressure, reduced fructosamine, and also marginally reduced plasma glucose concentrations. These results are indicative of a combinatorial effect of AST in assisting lipid and glucose metabolism in type 2 diabetes patients and provide a complementary therapy option for diabetic patients without adverse side effects.